Modifications of cupredoxin derived peptides and methods of use thereof

Details for Australian Patent Application No. 2010215875 (hide)

Owner CDG Therapeutics, Inc.

Inventors Das Gupta, Tapas; Beattie, Craig

Agent Shelston IP

Pub. Number AU-A-2010215875

PCT Pub. Number WO2010/096681

Priority 12/389,120 19.02.09 US

Filing date 19 February 2010

Wipo publication date 26 August 2010

International Classifications

C07K 14/00 (2006.01) Peptides having more than 20 amino acids

A61K 38/16 (2006.01) Medicinal preparations containing peptides - Peptides having more than 20 amino acids

Event Publications

22 September 2011 PCT application entered the National Phase

  PCT publication WO2010/096681 Priority application(s): WO2010/096681

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010215876-Power transfer management for local power sources of a grid-tied load

2010215874-Protein structural biomarkers to guide targeted chemotherapies